Shimadzu Corporation 7701

The global mass spectrometry market is projected to grow from USD 7.07 billion in 2026 to USD 10.78 billion by 2031, at an 8.8% CAGR. Growth is driven by precision medicine, biologics, multi-omics research, regulatory bioanalysis, and food and environmental testing. Instruments and LC-MS will lead the market, supported by high-resolution platforms, AI-enabled analytics, automation, and cloud-connected workflows. Pharmaceutical companies remain the largest end users, while Asia Pacific is expecte

The global life science instrumentation market is forecasted to grow from USD 63.4 billion in 2025 to USD 92.5 billion by 2031, at a CAGR of 6.5%. Key drivers include increased R&D funding, rising proteomics research, and growing disease prevalence. In 2025, the spectroscopy segment dominated the market owing to its integration in pharmaceutical and biotechnology research. The research applications sector is set to achieve the highest growth, with significant strides in genomics and drug discove

Recent performance and business profile Shimadzu (TSE:7701) has been on many watchlists after recent price moves, with the share price roughly flat over the past month and showing a negative total return over the past 3 months. Over the past year, investors have seen a 13.75% total return, while the year-to-date move is a decline of about 8.70%. Longer term, the 3-year total return is slightly negative, and the 5-year figure is close to flat. The company reports annual revenue of ¥553,473 and...

[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Environmental Mass Spectrometry Market size & share revenue was valued at approximately USD 2.84 Billion in 2025 and is expected to reach USD 3.12 Billion in 2026 and is expected to reach around USD 6.47 Billion by 2035, at a CAGR of 7.6% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are Thermo Fisher Sci

Shimadzu Medical Systems USA (SMS), a division of Shimadzu Precision Instruments, Inc. (SPI) which is fully owned by Shimadzu Corporation, Japan, is excited to announce it has renewed HCAI Special Seismic Certification approval for the RADspeed family.

The X-ray system market is poised for growth due to technological advances in imaging, increasing healthcare expenditure, and rising chronic disease cases. Key opportunities lie in the adoption of digital radiography and computed tomography, with key players like Siemens and GE Healthcare at the forefront of innovation. X-Ray System Market X-Ray System Market Dublin, Nov. 03, 2025 (GLOBE NEWSWIRE) -- The "X-Ray System Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2025-